Mazdutide

Mazdutide is an investigational dual receptor agonist that targets both the GLP-1 (glucagon-like peptide-1) receptor and the glucagon receptor. It is being studied for its potential effects on weight management, glucose regulation, and overall metabolic health.

By activating GLP-1 receptors, Mazdutide may help reduce appetite, slow gastric emptying, and improve insulin secretion, while glucagon receptor activity is thought to increase energy expenditure and promote fat utilization. This combined mechanism makes it a focus of research in obesity and type 2 diabetes management.

In clinical studies, it is being evaluated for its ability to produce meaningful weight reduction and improve metabolic markers. As an investigational compound, it is not yet widely approved for general medical use and remains under ongoing research.